Tennant Phil sold $132K of PGEN
Tennant Phil (Chief Commercial Officer) sold 30,272 shares of PRECIGEN, INC. (PGEN) at $4.36 ($0.13M total) on 2026-05-28.
How this was made
The 30-second read
Why it matters
The disclosure may slightly influence short-term sentiment among traders monitoring insider behavior, but it does not provide new company fundamentals (no guidance, trial, deal, or regulatory update).
Market read
Traders may treat this as a mild negative sentiment datapoint; conviction should be low without corroborating fundamental news.
What to watch
No 10b5-1 plan is noted, but the filing still lacks context (e.g., tax events, planned compensation exercises, or prior commitments) that would clarify informativeness.
Background
SEC Form 4 reports insider transactions; this filing discloses a Chief Commercial Officer’s direct open-market sale of Precigen shares.
Ticker impact
Pre-arranged 10b5-1 plan was not used; CCO Phil Tennant sold 30,272 shares of Precigen at $4.36 on 2026-05-28.
Likely limited near-term impact; any effect should fade unless followed by additional insider selling or new fundamentals.
This is an SEC Form 4 transaction disclosure with no accompanying company-specific operational or financial update; insider sales often have non-informational explanations.
Market effects
Minimal; this is company-specific insider activity with no stated sector-wide development.
None indicated.
None indicated.
Counterpoint
The sale was an open-market transaction and may be driven by diversification, taxes, or pre-existing personal liquidity needs rather than bearish expectations.
Key entities
- issuerPRECIGEN, INC.
Company whose insider transaction was disclosed on SEC Form 4.
- insiderTennant Phil
Chief Commercial Officer who sold 30,272 shares.
